|
|
| (634 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{CMG}} {{AE}} {{AKI}}
| |
|
| |
|
| | {{Roseola}} |
| | {{CMG}}:{{AE}}{{DAMI}} |
|
| |
|
| ==Overview==
| |
|
| |
|
| ==Historical Perspective== | | ==[[Roseola overview|Overview]]== |
| *In 1947, the first case of congenital varicella syndrome was reported.
| |
| *In 1987, Alkalay coined the term fetal varicella syndrome.
| |
|
| |
|
| ==Pathophysiology== | | ==[[Roseola historical perspective|Historical Perspective]]== |
|
| |
|
| ===Pathogenesis=== | | ==[[Roseola classification|Classification]]== |
| '''Primary infection during the period of gestation:'''
| |
| *Once a pregnant women has a primary varicella infection, transplacental transmission of the virus can take place affecting the fetus in utero. The clinical manifestations of the infection in the fetus are dependent on the gestational age of the fetus.
| |
| *An estimated of 25% fetuses are infected with varicella when the mother has a primary infection during the period of gestation, but only less than 2% of fetus develop congenital varicella syndrome.
| |
| *The risk of developing severe manifestations is high when the infection occurs between 13th and 20th weeks of gestation, which co-relate to the period of gestation when the innervation of the eyes and limbs occur.
| |
| *VZV is a neurotrophic virus and the pathogenesis of the wide variety of manifestations in the fetus is unclear, but it is proposed to be related to reactivation of the virus in the fetus and not related to the maternal VZV virus.
| |
| *VZV virus is present in the sensory ganglia of the posterior roots of the spinal cord during the latent phase, reactivation of the virus in results in the destruction of the nervous tissue resulting in the characteristic cicatrical skin lesions, limb hypoplasia, bladder denervation, and bulbar palsy.
| |
| *The presence of diffuse calcifications in the liver, spleen, myocardium and brain support a mechanism of hematogenous spread.
| |
| *VZV has a very short incubation period, between 8 to 14 days and the timing for identification of infection in the fetus is important.
| |
|
| |
|
| ==Epidemiology and Demographics== | | ==[[Roseola pathophysiology|Pathophysiology]]== |
|
| |
|
| ==Natural History, Prognosis and Complications== | | ==[[Roseola causes|Causes]]== |
| ===Natural History===
| |
| Varicella infection during pregnancy can result in congenital varicella syndrome, neonatal varicella and clinical zoster during infancy, the outcomes are dependent on the gestational age of fetus. Early gestational period infection via the transplacental route results in congenital varicella syndrome which presents with features such as low birthweight, cutaneous scarring, limb hypoplasia, microcephaly, cortical atrophy, chorioretinitis, cataracts. In cases with significant anomalies pregnancy is terminated and in newborns born with congenital varicella syndrome can have significant neurological deficits. The disease severity does not progress postnatally, therefore newborns with few features can have normal development.
| |
|
| |
|
| ===Prognosis=== | | ==[[Roseola differential diagnosis|Differentiating Any Disease from other Diseases]]== |
| Prognosis of infants with congenital varicella syndrome is poor. Infants die at a early age due to recurrent aspiration pneumonia and respiratory failure.
| |
| ===Complications===
| |
| *Fetal demise
| |
| *Intrauterine growth restriction
| |
| *Neurological deficits
| |
| *Developmental Delay
| |
|
| |
|
| ==Diagnosis== | | ==[[Roseola epidemiology and demographics|Epidemiology and Demographics]]== |
|
| |
|
| ===History and Symptoms=== | | ==[[Roseola risk factors|Risk Factors]]== |
| '''Symptoms of primary infection in Mother :'''
| |
| *Primary infection in the mother presents with fever, malaise and a maculopapular skin rash in the beginnning which becomes vesicular and crust over with healing. The disease is infectious 48 hours before the appearance of rash until the vesicles crust over.
| |
|
| |
|
| ===Physical Examination=== | | ==[[Roseola screening|Screening]]== |
| Clinical manifestations suggestive of Congenital varicella syndrome include:
| |
|
| |
|
| {| border="1"
| | ==[[Roseola natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
| |-
| |
| !
| |
| !'''Clinical Manifestations in congenital varicella syndrome'''
| |
| |-
| |
| !'''Skin'''
| |
| |
| |
| *Cicatricial lesions( Zig-Zag scarring in dermatomal distribution)
| |
| *Hypopigmentation
| |
| |-
| |
| !'''Eye'''
| |
| |
| |
| *Chorioretinitis
| |
| *Cataracts
| |
| *Micropthalmia
| |
| *Anisocoria
| |
| |-
| |
| !'''Central Nervous System'''
| |
| |
| |
| *Intrauterine encephalitis
| |
| *Cortical atrophy/porencephaly
| |
| *Seizures
| |
| *Mental retardation
| |
| *Autonomic instability
| |
| |-
| |
| !'''Musculoskeletal system'''
| |
| |
| |
| *Limb hypoplasia
| |
| *Muscle hypoplasia
| |
| |-
| |
| !'''Gastrointestinal'''
| |
| |
| |
| *Gastrointestinal reflux
| |
| |-
| |
| !'''Systemic Manifestations'''
| |
| |
| |
| *Intrauterine growth retardation
| |
| *Developmental delay
| |
| |-
| |
| !'''Urinary Tract'''
| |
| |
| |
| *Hydroureter
| |
| *Hydronephrosis
| |
| |}
| |
|
| |
|
| ===Laboratory Findings=== | | ==Diagnosis== |
| The diagnosis of congenital varicella syndrome is based on a documented history of varicella infection during the pregnancy and the presence of fetal manifestations on ultrasound.<br>
| | [[Roseola history and symptoms|History and Symptoms]] | [[Roseola physical examination|Physical Examination]] | [[Roseola laboratory findings|Laboratory Findings]] | [[Roseola electrocardiogram|Electrocardiogram]] | [[Roseola chest x ray|Chest X Ray]] | [[Roseola CT|CT]] | [[Roseola MRI|MRI]] | [[Roseola echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Roseola other imaging findings|Other Imaging Findings]] | [[Roseola other diagnostic studies|Other Diagnostic Studies]] |
| '''Diagnosis of primary infection in the mother :''' In pregnant women diagnosis of a primary infection requires a combination of clinical manifestations and series of diagnostic tests. The tests are performed on the samples from the vesicular skin lesions and include the following:
| |
| *Culture for VZV, but takes 10 to 12 days to obtain the results.
| |
| *Direct fluroscent antigen staining with monoclonal antibodies detects the VZV glycoproteins in the cells.
| |
| *PCR for the VZV
| |
| *Serological tests are not useful for the dectection of primary infection in the mother as it takes time for the IgG antibodies to be produced aganist VZV and majority of the women have a positive IgG as a result of vaccination or previous infection of varicella.
| |
| '''Prenatal Diagnosis'''
| |
| *Sequential ultrasound of the fetus is helpful to establish the presence of varicella infection and assess the severity of intrauterine infection.
| |
| *Amniocentesis should be performed 4 weeks after the primary infection in the mother, positive amniotic PCR for VZV can establish the presence of infection but does not provide evidence regarding the presence of infection or the severity of infection in the fetus. There is no established evidence to recommend amniocentesis for the diagnosis and is not performed on regular basis.
| |
| | |
| ===Imaging Studies===
| |
| ====Ultrasound====
| |
| *Sequential ultrasound in women with varicella infection during the period of gestation is the preffered diagnostic investigation to identify anomalies in the fetus. Ultrasound is usally done 4 weeks after the primary infection as earlier ultrasound might fail to detect anomalies. The findings suggestive of congenital varicella syndrome include limb deformities, microcephaly and hydrops.
| |
| *The following is a list of features that can be present in the fetus with varicella fetopathy:
| |
| **Cutaneous scars
| |
| **Musculoskeletal deformities such as limb hypoplasia and contractures
| |
| **Intrauterine growth restriction
| |
| **Ventriculomegaly, microcephaly with polymicrogyria, and porencephaly
| |
| **Micropthalmia and congenital cataracts
| |
| **Calcification in the brain, spleen and liver
| |
| **Features of Hydrops fetalis such as skin edema, hepatosplenomegaly
| |
| **Polyhydramnios
| |
| | |
| ====MRI====
| |
|
| |
|
| ==Treatment== | | ==Treatment== |
| | [[Roseola medical therapy|Medical Therapy]] | [[Roseola surgery|Surgery]] | [[Roseola primary prevention|Primary Prevention]] | [[Roseola secondary prevention|Secondary Prevention]] | [[Roseola cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Roseola future or investigational therapies|Future or Investigational Therapies]] |
|
| |
|
| ===Medical Therapy=== | | ==Case Studies== |
| *Varicella infection doesnot progress postnatally, so treatment with acyclovir is not indicated.<ref name="HarishJamwal2009">{{cite journal|last1=Harish|first1=Rekha|last2=Jamwal|first2=Ashu|last3=Dang|first3=Ketan|title=Congenital varicella syndrome/ vericella zoster virus VZV fetopathy|journal=The Indian Journal of Pediatrics|volume=77|issue=1|year=2009|pages=92–93|issn=0019-5456|doi=10.1007/s12098-009-0259-y}}</ref>
| | [[Roseola case study one|Case #1]] |
| | |
| ===Surgical Therapy===
| |
| | |
| ==Prevention==
| |
| | |
| ===Primary Prevention===
| |
| *Documentation of previous varicella infection and vaccination status in all pregnant women at the first antenatal visit.
| |
| *If the pregnant women has no previous infection or is not vaccinated, VZV IgG antibody testing must be done to determine the maternal immune status.
| |
| *In pregnant women with positive IgG, pregnant women are reassured that the IgG antibodies would protect the baby.
| |
| *In pregnant women with negative IgG, counseling regarding the risks of varicella infection and education regarding the measures to avoid contact with varicella are recommended as vaccination aganist VZV is contraindicated during the pregnancy.
| |
| *Women who are seronegative should recieve two doses of the vaccine during the postpartum period 4 to 8 weeks apart with no effect on breast feeding.
| |
| *Women can be vaccinated during the preconception period, but are adviced to avoid conceiving for a month after the last dose of the vaccine.
| |
| | |
| ===Secondary Prevention===
| |
| *In pregnant women with exposure to varicella, passive immunization with varicella zoster virus antibodies (VZV IgG) should be administered after 72-96 hours of exposure as postexposure prophylaxis. Passive immunization is not proven to reduce viremia therefore its role in preventing congenital varicella syndrome is not well established. It is only recommended to prevent maternal complications of varicella in pregnancy.<ref name="pmid21262937">{{cite journal| author=Cohen A, Moschopoulos P, Maschopoulos P, Stiehm RE, Koren G| title=Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin. | journal=CMAJ | year= 2011 | volume= 183 | issue= 2 | pages= 204-8 | pmid=21262937 | doi=10.1503/cmaj.100615 | pmc=3033924 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21262937 }} </ref>
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |